Our results are further supported by a very recent study which demonstrates that human melanoma cells co-cultured in the presence of fibroblasts undergo a phenotype switch toward mesenchymal-like cells, activate the PI3K-Akt/mTOR signaling pathway and become resistant to the BRAF inhibitor vemurafenib52. Here, MTOR is linked to melanoma.